Evidence map›Paper›PMID 41728946›Full record

ArticleNucleic acids research2026

CRISPR-associated transposon for programmable viral vector engineering and prime editing.

Quyen T Dang, Chin-Wei Chang, Pin-Yan Chen, Vy A Truong, Pei-Yi Huang, Mai T Thi Nguyen, Yu-Chen Hu

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Quyen T DangDepartment of Chemical Engineering, National Tsing Hua University, Hsinchu 300044, Taiwan.
Chin-Wei ChangDepartment of Chemical Engineering, National Tsing Hua University, Hsinchu 300044, Taiwan.
Pin-Yan ChenDepartment of Chemical Engineering, National Tsing Hua University, Hsinchu 300044, Taiwan.
Vy A TruongDepartment of Chemical Engineering, National Tsing Hua University, Hsinchu 300044, Taiwan.
Pei-Yi HuangDepartment of Chemical Engineering, National Tsing Hua University, Hsinchu 300044, Taiwan.
Mai T Thi NguyenFaculty of Chemistry, University of Science, Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam.
Yu-Chen HuDepartment of Chemical Engineering, National Tsing Hua University, Hsinchu 300044, Taiwan.ORCID 0000-0002-9997-4467

Funding

National Science and Technology CouncilNational Science and Technology Council 112-2223-E-007-002National Science and Technology Council 112-2622-E-007-030National Science and Technology Council 113-2223-E-007-010National Science and Technology Council 113-2321-B-007-004National Science and Technology Council 113-2622-E-007-012National Science and Technology Council NSTC 114-2223-E-007-013University System of Taiwan VGHUST115-G6-1-1University System of Taiwan Joint Research Program VGHUST115-G6-1-1Veterans General Hospitals
6 · The paper itself

Abstract

Baculovirus, an insect virus commonly used for recombinant protein expression in insect cells and gene delivery in mammalian systems, is often generated through bacmid-based engineering. To enable flexible and programmable bacmid engineering, we developed SHOT 2.0, an optimized CRISPR-associated transposon platform that mediates RNA-guided and customized bacmid editing in Escherichia coli. The edited bacmid can be transfected into insect cells to produce recombinant baculoviruses. SHOT 2.0 supported site-specific integration of large DNA cargos (at least 14 kb) into defined loci such as v-cath and ODVe56, with integration at ODVe56 markedly improving transgene stability during serial virus passaging. The system is fully compatible with the Bac-to-Bac® workflow, enabling dual-gene insertion into the bacmid and derived baculovirus. Leveraging this platform, we constructed an all-in-one baculovirus encoding the PE5max prime editor. This vector-mediated prime editing achieves efficiencies up to 85.6% in HEK293T cells and achieves robust prime editing in hard-to-transfect cell types, including iPSCs and liver cancer cells, with efficiencies up to 37.1%. These results demonstrate that SHOT 2.0 substantially expands the baculovirus engineering toolbox, providing a flexible platform for genome editing and future gene delivery.

Indexed as

BaculoviridaeCRISPR-Cas SystemsDNA Transposable ElementsGene EditingGenetic VectorsAnimalsEscherichia coliHEK293 CellsHumansInduced Pluripotent Stem CellsTransgenesDNA Transposable Elements

Identifiers

PMID41728946
PMCPMC12926911

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.